Literature DB >> 7105488

An adoptive cell transfer system for the evaluation of immunity to Herpes simplex virus in mice.

L Favila, E L Howes, W A Taylor, N A Mitchison.   

Abstract

Lymphocytes adoptively transferred from syngeneic immune donors protect mice against challenge with Herpes simplex virus type 1. Normal mice require transfer 3 x 10(7) spleen cells for protection. Sublethal irradiation (450 rad) decreases the number required five-fold. Lymphocytes from non-immune donors do not protect, and hyperimmunization does not enhance the protection efficiency of donors. The viral LD50 varies through a range 10(5)-fold during the period of recovery from this amount of radiation, but over the same period there is little variation in the number of cells required for protection. Nor is there much variation in this number between strains of mice naturally susceptible (CBA) and resistant (C57) to the virus. We conclude that natural resistance operates at a level of virus handling prior to operation of the lymphocyte system, perhaps at the generation of interferon. As few as 1.3 x 10(6) immune T lymphocytes can protect against challenge provided that they are transferred together with normal spleen cells. We conclude that primed lymphocytes act in co-operation with non-immune cells.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7105488      PMCID: PMC1536478     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  14 in total

1.  Genetics of natural resistance to herpesvirus infections in mice.

Authors:  C Lopez
Journal:  Nature       Date:  1975-11-13       Impact factor: 49.962

2.  Role for cell-mediated immunity in the resistance of mice to subcutaneous herpes simplex virus infection.

Authors:  J E Oakes
Journal:  Infect Immun       Date:  1975-07       Impact factor: 3.441

3.  Plasmodium chabaudi in mice. Adoptive transfer of immunity with enriched populations of spleen T and B lymphocytes.

Authors:  V McDonald; R S Phillips
Journal:  Immunology       Date:  1978-05       Impact factor: 7.397

4.  A rapid method for the isolation of functional thymus-derived murine lymphocytes.

Authors:  M H Julius; E Simpson; L A Herzenberg
Journal:  Eur J Immunol       Date:  1973-10       Impact factor: 5.532

5.  Host defense mechanisms against herpes simplex virus. II. Protection conferred by sensitized spleen cells.

Authors:  F A Ennis
Journal:  J Infect Dis       Date:  1973-06       Impact factor: 5.226

6.  Macrophages and age-dependent resistance to Herpes simplex virus in mice.

Authors:  M S Hirsch; B Zisman; A C Allison
Journal:  J Immunol       Date:  1970-05       Impact factor: 5.422

7.  Enhanced cytotoxicity of mouse natural killer cells for vaccinia and herpes virus-infected targets.

Authors:  G E Piontek; R Weltzin; W A Tompkins
Journal:  J Reticuloendothel Soc       Date:  1980-02

8.  Mechanism of immunologic resistance to herpes simplex virus 1 (HSV-1) infection.

Authors:  B Rager-Zisman; A C Allison
Journal:  J Immunol       Date:  1976-01       Impact factor: 5.422

9.  H-2 compatibility requirement for virus-specific T cell-mediated effector functions in vivo. I. Specificity of T cells conferring antiviral protection against lymphocytic choriomeningitis virus is associated with H-2K and H-2D.

Authors:  R M Zinkernagel; R M Welsh
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

10.  H-2 restriction of cell-mediated immunity to an intracellular bacterium: effector T cells are specific for Listeria antigen in association with H-21 region-coded self-markers.

Authors:  R M Zinkernagel; A Althage; B Adler; R V Blanden; W F Davidson; U Kees; M B Dunlop; D C Shreffler
Journal:  J Exp Med       Date:  1977-05-01       Impact factor: 14.307

View more
  3 in total

1.  The metabolism of neuropeptides. The hydrolysis of peptides, including enkephalins, tachykinins and their analogues, by endopeptidase-24.11.

Authors:  R Matsas; A J Kenny; A J Turner
Journal:  Biochem J       Date:  1984-10-15       Impact factor: 3.857

2.  Expression of immunity to intravaginal herpes simplex virus type 2 infection in the genital tract and associated lymph nodes.

Authors:  M R McDermott; P L Brais; G C PLoettsche; M J Evelegh; C H Goldsmith
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

3.  Protective immunization of mice with specific HSV-1 glycoproteins.

Authors:  W L Chan
Journal:  Immunology       Date:  1983-06       Impact factor: 7.397

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.